Telix and Regeneron Unite: A Groundbreaking Alliance for Radiopharmaceutical Innovation
A Second Chance for Hope: Telix Resubmits Pioneering Brain Cancer Imaging Agent, Pixclara, to FDA
A New Chapter in Oncology: Telix Unveils Cutting-Edge Manufacturing Facility in Japan
Telix Pharmaceuticals Faces Second Major FDA Hurdle for Critical Kidney Cancer Diagnostic